Treatment of severe acute respiratory syndrome (Q36261771)

13 August 2017

1 reference

title

Treatment of severe acute respiratory syndrome (English)

1 reference

13 August 2017

Lai ST

1

1 reference

13 August 2017

1 September 2005

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

13 August 2017

1 reference

13 August 2017

24

1 reference

13 August 2017

583-591

1 reference

13 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-005-0004-z

13 August 2017

0 references

cites work

Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-0004-Z

Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-0004-Z

Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-0004-Z

Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-0004-Z

Interferon-beta 1a and SARS coronavirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-0004-Z

Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-0004-Z

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

21 January 2018

1 reference

12 December 2020

Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

1 reference

12 December 2020

SARS treatment: experience from a team in Guangdong, China.

1 reference

12 December 2020

Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study

1 reference

12 December 2020

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

1 reference

12 December 2020

SARS: ventilatory and intensive care

1 reference

12 December 2020

Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

1 reference

12 December 2020

Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.

1 reference

12 December 2020

Chest X ray changes in severe acute respiratory syndrome cases after discontinuation of glucocorticosteroids treatment.

1 reference

12 December 2020

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

1 reference

12 December 2020

Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol

1 reference

12 December 2020

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

1 reference

12 December 2020

Identification of severe acute respiratory syndrome in Canada

1 reference

12 December 2020

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

1 reference

12 December 2020

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

1 reference

12 December 2020

Clinical study on treatment of severe acute respiratory syndrome with integrative Chinese and Western medicine approach

1 reference

12 December 2020

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

1 reference

12 December 2020

Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

1 reference

12 December 2020

Antiviral treatment of SARS: can we draw any conclusions?

1 reference

12 December 2020

ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome.

1 reference

12 December 2020

High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome

1 reference

12 December 2020

Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.

1 reference

12 December 2020

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha

1 reference

12 December 2020

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

12 December 2020

Inhibition of SARS-associated coronavirus infection and replication by RNA interference.

1 reference

12 December 2020

Severe acute respiratory syndrome-related diarrhea.

1 reference

12 December 2020

Treating severe acute respiratory syndrome with hyperimmune globulins

1 reference

12 December 2020

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.

1 reference

12 December 2020

Retrospective analysis of the corticosteroids treatment on severe acute respiratory syndrome (SARS)

1 reference

12 December 2020

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

1 reference

12 December 2020

Aminopeptidase N inhibitors and SARS

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with convalescent plasma

1 reference

12 December 2020

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

1 reference

12 December 2020

Management of hospital-acquired severe acute respiratory syndrome with different disease spectrum.

1 reference

12 December 2020

Lopinavir/ritonavir: a review of its use in the management of HIV infection

1 reference

12 December 2020

Controlled clinical study on 49 patients of SARS treated by integrative Chinese and Western medicine

1 reference

12 December 2020

Treatment of SARS with human interferons

1 reference

12 December 2020

Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

Bronchiolitis obliterans organizing pneumonia

1 reference

12 December 2020

Critics slam treatment for SARS as ineffective and perhaps dangerous

1 reference

12 December 2020

Use of convalescent plasma therapy in SARS patients in Hong Kong.

1 reference

12 December 2020

Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation

1 reference

12 December 2020

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome in health-care workers

1 reference

12 December 2020

Severe acute respiratory syndrome (SARS) and coronavirus testing--United States, 2003

1 reference

12 December 2020

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

12 December 2020

Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs

1 reference

12 December 2020

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

1 reference

12 December 2020

Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids

1 reference

12 December 2020

Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection

1 reference

12 December 2020

Development of a standard treatment protocol for severe acute respiratory syndrome

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

SARS: pharmacotherapy

1 reference

12 December 2020

TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection.

1 reference

12 December 2020

The Use of Corticosteroids in SARS

1 reference

12 December 2020

Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound

1 reference

12 December 2020

Consensus for the management of severe acute respiratory syndrome.

1 reference

12 December 2020

Update: severe acute respiratory syndrome--United States, 2003.

1 reference

12 December 2020

Pentaglobin in steroid-resistant severe acute respiratory syndrome.

1 reference

12 December 2020

Ribavirin in the treatment of severe acute respiratory syndrome (SARS)

1 reference

12 December 2020

Managing SARS amidst uncertainty

1 reference

12 December 2020

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.

1 reference

12 December 2020

The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase

1 reference

12 December 2020

Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western Medicine

1 reference

12 December 2020

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

1 reference

12 December 2020

Lung pathology of fatal severe acute respiratory syndrome.

1 reference

12 December 2020

Avascular necrosis of bone in severe acute respiratory syndrome

1 reference

12 December 2020

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

1 reference

12 December 2020

Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

1 reference

12 December 2020

Novel coronavirus and severe acute respiratory syndrome

1 reference

12 December 2020

Role for macrophage migration inhibitory factor in acute respiratory distress syndrome.

1 reference

12 December 2020

Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS.

1 reference

12 December 2020

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

1 reference

12 December 2020

Management of severe acute respiratory syndrome: the Hong Kong University experience.

1 reference

12 December 2020

Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design

1 reference

12 December 2020

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

1 reference

12 December 2020

Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak.

1 reference

12 December 2020

Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome

1 reference

12 December 2020

Our strategies for fighting severe acute respiratory syndrome (SARS).

1 reference

12 December 2020

Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma).

1 reference

12 December 2020

Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome.

1 reference

12 December 2020

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study

1 reference

12 December 2020

Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors

1 reference

12 December 2020

Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease.

1 reference

12 December 2020

Osteonecrosis in children with severe acute respiratory syndrome

1 reference

12 December 2020

10.1007/S10096-005-0004-Z

Identifiers

DOI

1 reference

13 August 2017

0 references

1 reference

PubMed ID

16172857